Literature DB >> 8847152

Intravenous lignocaine in the management of primary fibromyalgia syndrome.

M I Bennett1, Y M Tai.   

Abstract

Ten patients with primary fibromyalgia syndrome were treated with intravenous infusions of lignocaine on a daily basis for six days. This treatment produced a clinically useful improvement in pain relief and mood scores at the time of discharge on day seven and at follow-up on day thirty.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8847152

Source DB:  PubMed          Journal:  Int J Clin Pharmacol Res        ISSN: 0251-1649


  7 in total

1.  Fibromyalgia: revisiting the literature.

Authors:  Diane Forbes; Andrew Chalmers
Journal:  J Can Chiropr Assoc       Date:  2004-06

Review 2.  Management of fibromyalgia syndrome in 2016.

Authors:  Akiko Okifuji; Jeff Gao; Christina Bokat; Bradford D Hare
Journal:  Pain Manag       Date:  2016-06-16

Review 3.  Management of fibromyalgia.

Authors:  Ashwin A Patkar; Louai Bilal; Prakash S Masand
Journal:  Curr Psychiatry Rep       Date:  2003-07       Impact factor: 5.285

4.  Intravenous lidocaine for fibromyalgia syndrome: an open trial.

Authors:  Marcelo Derbli Schafranski; Tiago Malucelli; Fabíola Machado; Hélcio Takeshi; Flávia Kaiber; Carolina Schmidt; Fabielle Harth
Journal:  Clin Rheumatol       Date:  2009-03-05       Impact factor: 2.980

5.  Pharmacological treatment of fibromyalgia syndrome: new developments.

Authors:  Roland Staud
Journal:  Drugs       Date:  2010       Impact factor: 9.546

6.  Lidocaine in fibromyalgia: A systematic review.

Authors:  Jozélio Freire de Carvalho; Thelma L Skare
Journal:  World J Psychiatry       Date:  2022-04-19

7.  Efficacy and adverse effects of intravenous lignocaine therapy in fibromyalgia syndrome.

Authors:  J H Raphael; J L Southall; G J Treharne; G D Kitas
Journal:  BMC Musculoskelet Disord       Date:  2002-09-08       Impact factor: 2.362

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.